GENE THERAPY WITH ENGINEERED MACROPHAGES
- 2 Years 1996/1998
 - 92.962€ Total Award
 
Description unavailable
Scientific Publications
- 2002 CELLULAR IMMUNOLOGY 
Antagonistic effect of picolinic acid and interferon-gamma on macrophage inflammatory protein-1 alpha/beta production
 - 2001 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND L 
New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids
 - 2001 GENE THERAPY 
Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer
 - 1997 JOURNAL OF BIOLOGICAL CHEMISTRY 
Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine
 - 2001 JOURNAL OF IMMUNOLOGY 
Engineering of macrophages to produce IFN-gamma in response to hypoxia
 - 1997 JOURNAL OF IMMUNOLOGY 
Functional role for the myeloid differentiation antigen CD14 in the activation of human monocytes by IL-2
 - 2000 JOURNAL OF IMMUNOLOGY 
The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and-1 beta in macrophages